Pfizer has issued a voluntary recall of four million packages of Nurtec ODT. The migraine medication is reportedly a risk. It’s because its packaging is not child resistant. It poses a poisoning risk.
Prescription drugs must be in child-resistant packaging. This is now required by the Poison Prevention Packaging Act.
The Nurtec ODT tablets are in a blister card that’s not child resistant. It’s packaged in a carton that shows the product’s name and dosage strength. It also carries the end date and NDC number.
Pfizer has not received any reports of incidents involving the recalled prescription drug.
What are the Affected Products?
The massive recall involves Nurtec ODT 75 mg. It’s a tablet that disintegrates in an oral manner. These tablets are always sold in cartons. Each carton contains a blister card with eight tablets. The affected medication carries dates all the way through June 2026. It also has the NDC number 72618-3000-2.
The Nurtec tablets were reportedly manufactured in the US. They’re sold at pharmacies all over the country. The medication was available from December 2021 to March 2023. The product price varies as it’s based on the patient’s health insurance terms. There are other mitigating factors as well.
What Should Consumers Do?
Consumers using migraine medication should place it out of reach of children. They should then contact Pfizer and request a child-resistant pouch. It’s for storing medicine. The company will send it for free.
The consumer can continue to use Nurtec ODT once they have secured the medicine. Patients don’t need to throw away the tablets. They also don’t need to stop taking the medicine. There are no safety or quality issues connected with the migraine tablets.Consumers can also call Pfizer’s toll-free number at (800) 879-3477. The company is open Mondays to Fridays, 9 AM to 7 PM (ET). They can also check www.Nurtec.com/PackagingUpdate for more details.